QT
TPST icon

Quantbot Technologies’s Tempest Therapeutics TPST Stock Holding History

Quantbot Technologies’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed – – 1685
2020
Q3 		$0 Buy
+1
New +$339 ﹤0.01% 1641
2015
Q4 		– Sell
-1
Closed -$16K – 1364
2015
Q3 		$16K Buy
+1
New +$67.3K ﹤0.01% 1043
2015
Q1 		– Hold
0
– -$49K – 1352
2014
Q4 		– Hold
0
– – – 835

Other funds holding TPST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Quantbot Technologies's TPST Position: Q4 2020 in Review

Quantbot Technologies sold out of Tempest Therapeutics (TPST) in Q4 2020, closing a stake of 1 share.

Quantbot Technologies first reported a position in TPST in Q3 2015 and held it in 2 quarters. The position peaked at $16K in Q3 2015. 37 funds tracked by Wall St. Rank hold TPST as of Q4 2020.

  • Quantbot Technologies reported no remaining Tempest Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Quantbot Technologies sold 1 Tempest Therapeutics share in Q4 2020.
  • Quantbot Technologies first reported a position in Tempest Therapeutics in Q3 2015 and held it in 2 quarters.
  • Quantbot Technologies's Tempest Therapeutics position peaked at $16K in Q3 2015.
  • 37 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2020.

Based on Quantbot Technologies's 13F filing for Q4 2020, filed 12 Feb 2021.